Can light help treat Parkinson’s symptoms?
Light therapy as a potential treatment for Parkinson’s hits the headlines. We take a deeper look at what we know about it so far.
Parkinson’s community boosts recruitment to clinical studies
Back in the summer, we called upon the Parkinson’s community to take part in 5 clinical trials that were at a potential risk of closing. Thanks to you, we had an incredible response and want to keep up the momentum of encouraging people to take part in research.
NRG Therapeutics attracts a further £16m to develop treatments that could slow Parkinson's
The biotech company NRG Therapeutics has received a large investment to continue its drug development project into life-changing new treatments.
Next steps for landmark stem cell study approved
An international clinical trial looking at using stem cells to treat Parkinson’s has been granted approval to go ahead initially in Sweden.
We’re partnering with Enterin to develop a potential new treatment for Parkinson’s dementia
We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.
Making progress towards a potential new GDNF trial
Over the last 2 years, Vivifi Biotech has made progress towards a trial that aims to overcome the challenges of the last trial. Now, it’s starting work on the final phase of planning.
Ex-international rugby players have an increased risk of developing Parkinson’s
A study following Scottish international rugby players shows they are more likely to develop neurodegenerative conditions compared to the general public.
Artificial intelligence to help identify Parkinson’s
A project involving Parkinson’s UK, shows promise for using artificial intelligence to identify Parkinson’s in brains donated to our Brain Bank.
Hormone produced during exercise protects brain cells in mice
Results from a US study show that a hormone called irisin has the potential to halt the progression of Parkinson’s in mice.